Study details
Enrolling now
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
University of Washington, the Collaborative Health Studies Coordinating Center
NCT IDNCT06654752ClinicalTrials.gov data as of Apr 2026
Target enrollment
430
Study length
about 4.2 years
Ages
3–18
Locations
31 sites in AL, AZ, CA +21
About this study
This trial is testing whether a streamlined approach to treating pulmonary exacerbations (PEx) in children with cystic fibrosis (CF) is safe and effective. It compares two different antibiotic treatment strategies for managing PEx, one using immediate oral antibiotics and the other only prescribing oral antibiotics if additional treatment is needed.
Based on ClinicalTrials.gov records.
What participants do
- 1.Immediate Oral Antibiotics
- 2.Tailored Treatment: Oral Antibiotics only if Additional Treatment needed
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low6%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Respiratory